Larisa V Gubareva Selected Research

Adamantane

1/2012	The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
1/2011	Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.
3/2010	Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.
7/2009	Influenza genome analysis using pyrosequencing method: current applications for a moving target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larisa V Gubareva Research Topics

Disease

70	Human Influenza (Influenza) 01/2022 - 12/2002
34	Infections 01/2022 - 03/2006
8	Influenza in Birds (Avian Flu) 01/2016 - 04/2006
3	Virus Diseases (Viral Diseases) 10/2021 - 02/2012
2	Body Weight (Weight, Body) 12/2016 - 05/2015
2	Weight Loss (Weight Reduction) 04/2014 - 03/2006
1	Hemolysis 04/2014
1	Conjunctivitis 03/2012
1	Herpesviridae Infections (Herpesvirus Infection) 06/2010
1	Orthomyxoviridae Infections 03/2010

Drug/Important Bio-Agent (IBA)

40	Neuraminidase (Sialidase)IBA 01/2022 - 07/2004
34	Oseltamivir (Tamiflu)FDA Link 10/2021 - 03/2006
30	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2009
20	Pharmaceutical PreparationsIBA 10/2021 - 07/2009
11	Zanamivir (Relenza)FDA Link 10/2021 - 03/2008
9	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 12/2002
5	baloxavirIBA 01/2022 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2006
4	VaccinesIBA 10/2017 - 11/2009
4	oplunofuspIBA 08/2014 - 04/2006
4	AdamantaneIBA 01/2012 - 07/2009
3	EndonucleasesIBA 01/2022 - 01/2019
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2017 - 10/2005
3	peramivirIBA 09/2013 - 08/2006
2	Monoclonal AntibodiesIBA 12/2016 - 01/2011
2	laninamivirIBA 09/2013 - 01/2013
2	Amino Acids FDA Link 04/2011 - 04/2009
2	cyanovirin NIBA 12/2008 - 01/2007
1	AntigensIBA 10/2017
1	AntibodiesIBA 01/2017
1	IsotopesIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	Immune Sera (Antisera)IBA 04/2014
1	NucleotidesIBA 08/2012
1	PolymersIBA 03/2011
1	EnzymesIBA 09/2010
1	favipiravirIBA 06/2010
1	Rimantadine FDA LinkGeneric 03/2010
1	Amantadine (Aman)FDA LinkGeneric 03/2010
1	poly(isobutylene-alt-maleic anhydride)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 04/2009
1	Histidine (L-Histidine)FDA Link 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 12/2008
1	PlacebosIBA 12/2008
1	N,N-dodecyl,methyl-polyethylenimineIBA 03/2008
1	methyl inosine monophosphate (MIMP)IBA 08/2006
1	Inosine FDA Link 08/2006
1	Immunologic Factors (Immunomodulators)IBA 08/2006
1	Sialic AcidsIBA 04/2006
1	Recombinant Fusion ProteinsIBA 04/2006
1	sialic acid receptorIBA 04/2006
1	A-322278IBA 03/2006
1	Polysaccharides (Glycans)IBA 10/2005

Therapy/Procedure

7	Therapeutics 12/2016 - 03/2006
2	Chemoprevention 01/2012 - 01/2012
1	Treatment Delay 12/2016
1	Long-Term Care 12/2009
1	Aftercare (After-Treatment) 12/2008